Equities Analysts Set Expectations for Protagonist Therapeutics, Inc.’s FY2028 Earnings (NASDAQ:PTGX)
Protagonist Therapeutics, Inc. (NASDAQ:PTGX – Free Report) – Stock analysts at Capital One Financial issued their FY2028 earnings per share estimates for shares of Protagonist Therapeutics in a report released on Wednesday, January 31st. Capital One Financial analyst T. Chiang anticipates that the company will earn ($0.95) per share for the year. Capital One Financial […]
More Stories
Fallout Nuka Girl: Release Date, Pricing and More
Have you ever explored the world of the Fallout video gaming series? If yes, you must have probably seen the...
US to Host New Israel–Lebanon Peace Talks
By Ryan Morgan The United States will again host a set of talks between Israeli and Lebanese delegations on May...
US Fighter Jet Disables 2 Iranian Tankers in Blockade Enforcement Action: CENTCOM
By Ryan Morgan A U.S. fighter jet fired on a pair of crude oil tankers as they attempted to bypass...
OpenAI Cofounder Greg Brockman Defends Company’s For-Profit Pivot—and His Own $30 Billion Payday
By Beige Luciano-Adams In the second week of a high-profile jury trial that could have a profound impact on the...
Trump Put Tehran on the Clock
By Mehek Cooke President Donald Trump’s usual naysayers and the foreign policy class are already trying to sell his pause...
US Economy Adds 115,000 Jobs in April, Beating Market Estimates
By Andrew Moran The U.S. labor market could be showing signs of heating up after the economy topped economists’ expectations....